Tutorials
Eli Lilly and Co logo

Eli Lilly and Co

$ 300.57 -4.04 (-1.33%) 03:45 PM EST
On watch
P/E:
48.70
P/B:
33.47
Market Cap:
$ 285.96B
Enterprise V:
$ 303.67B
Volume:
1.65M
Avg Vol (2M):
2.77M
Also Trade In:
Volume:
1.65M
Market Cap $:
285.96B
PE Ratio:
48.70
Avg Vol (2-Month):
2.77M
Enterprise Value $:
303.67B
PB Ratio:
33.47
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Eli Lilly and Co
NAICS : 325412 SIC : 2834
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Description
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Financials (Next Earnings Date:2022-10-26 Est.)

LLY's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:LLY

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 29,070.7
EPS (TTM) ($) 6.18
Beta 0.4
Volatility % 27.74
14-Day RSI 36.68
14-Day ATR ($) 7.406676
20-Day SMA ($) 320.606
12-1 Month Momentum % 22.65
52-Week Range ($) 220.2 - 335.33
Shares Outstanding (Mil) 950.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Eli Lilly and Co Filings

Document Form Filing Date
No Filing Data

Headlines

See More